149 related articles for article (PubMed ID: 38216290)
1. Performance of the Rheumatoid Arthritis Impact of Disease (RAID) score in relation to flares in disease activity.
Holten K; Paulshus Sundlisæter N; Sexton J; Nordberg LB; Uhlig T; Kvien TK; Solomon DH; Haavardsholm EA; Lillegraven S; Aga AB;
RMD Open; 2024 Jan; 10(1):. PubMed ID: 38216290
[TBL] [Abstract][Full Text] [Related]
2. Validity of the rheumatoid arthritis impact of disease (RAID) score and definition of cut-off points for disease activity states in a population-based European cohort of patients with rheumatoid arthritis.
Salaffi F; Di Carlo M; Vojinovic J; Tincani A; Sulli A; Soldano S; Andreoli L; Dall'Ara F; Ionescu R; Simić Pašalić K; Balčune I; Ferraz-Amaro I; Tlustochowicz M; Butrimienė I; Punceviciene E; Toroptsova N; Grazio S; Morović-Vergles J; Masaryk P; Otsa K; Bernardes M; Boyadzhieva V; Cutolo M
Joint Bone Spine; 2018 May; 85(3):317-322. PubMed ID: 28549945
[TBL] [Abstract][Full Text] [Related]
3. Effect of Half-Dose vs Stable-Dose Conventional Synthetic Disease-Modifying Antirheumatic Drugs on Disease Flares in Patients With Rheumatoid Arthritis in Remission: The ARCTIC REWIND Randomized Clinical Trial.
Lillegraven S; Paulshus Sundlisæter N; Aga AB; Sexton J; Olsen IC; Fremstad H; Spada C; Madland TM; Høili CA; Bakland G; Lexberg Å; Hansen IJW; Hansen IM; Haukeland H; Ljoså MA; Moholt E; Uhlig T; Solomon DH; van der Heijde D; Kvien TK; Haavardsholm EA
JAMA; 2021 May; 325(17):1755-1764. PubMed ID: 33944875
[TBL] [Abstract][Full Text] [Related]
4. Pain and Self-reported Swollen Joints Are Main Drivers of Patient-reported Flares in Rheumatoid Arthritis: Results from a 12-month Observational Study.
Kuettel D; Primdahl J; Weber U; Terslev L; Østergaard M; Petersen R; Pedersen AK; Möller S; Hørslev-Petersen K
J Rheumatol; 2020 Sep; 47(9):1305-1313. PubMed ID: 31787604
[TBL] [Abstract][Full Text] [Related]
5. Validation and predictive capacity of a Dutch version of the FLARE-RA questionnaire within the context of a TNFi-tapering trial.
Doumen M; Bertrand D; Pazmino S; De Cock D; Stouten V; Joly J; de Wergifosse I; Moeyersoons A; Westhovens R; Verschueren P
Clin Rheumatol; 2023 Jan; 42(1):39-45. PubMed ID: 35943667
[TBL] [Abstract][Full Text] [Related]
6. Onset of action of etanercept in rheumatoid arthritis based on patient-reported outcomes.
Dougados M; Ripert M; Hilliquin P; Brocq O; Brault Y; Logeart I
Clin Exp Rheumatol; 2012; 30(2):266-8. PubMed ID: 22325048
[TBL] [Abstract][Full Text] [Related]
7. Clinical performance of rheumatoid arthritis impact of disease score: a real-life evidence from the multicenter nationwide registry BioStaR.
Melikoglu MA; Ataman S; Bodur H; Cay HF; Capkin E; Akgul O; Cevik R; Gogus F; Kamanli A; Yurdakul FG; Gurer G; Yagci I; Rezvani A; Duruoz MT; Sunar I
Rheumatol Int; 2021 Nov; 41(11):1971-1978. PubMed ID: 34559275
[TBL] [Abstract][Full Text] [Related]
8. The American English version of the validated French Flare Assessment in RA Questionnaire (FLARE-RA).
Barroso N; Woodworth TG; Furst DE; Guillemin F; Fautrel BJ; Borazan N; Kafaja S; Brook J; Elashoff DA; Ranganath VK
Clin Rheumatol; 2020 Jan; 39(1):189-199. PubMed ID: 31493148
[TBL] [Abstract][Full Text] [Related]
9. Performances of Clinical Disease Activity Index (CDAI) and Simplified Disease Activity Index (SDAI) appear to be better than the gold standard Disease Assessment Score (DAS-28-CRP) to assess rheumatoid arthritis patients.
Dhaon P; Das SK; Srivastava R; Dhakad U
Int J Rheum Dis; 2018 Nov; 21(11):1933-1939. PubMed ID: 28608433
[TBL] [Abstract][Full Text] [Related]
10. Disease flares in rheumatoid arthritis are associated with joint damage progression and disability: 10-year results from the BeSt study.
Markusse IM; Dirven L; Gerards AH; van Groenendael JH; Ronday HK; Kerstens PJ; Lems WF; Huizinga TW; Allaart CF
Arthritis Res Ther; 2015 Aug; 17(1):232. PubMed ID: 26321751
[TBL] [Abstract][Full Text] [Related]
11. Correlates of Successful Rheumatoid Arthritis Flare Management: Clinician-driven Treatment, Home-based Strategies, and Medication Change.
Mahmoud TG; Huang J; Frits M; Iannaccone C; Bykerk V; Bingham CO; Weinblatt M; Shadick NA
J Rheumatol; 2020 Mar; 47(3):333-340. PubMed ID: 31203222
[TBL] [Abstract][Full Text] [Related]
12. Definition and construct validation of clinically relevant cutoffs on the Flare Assessment in Rheumatoid Arthritis (FLARE-RA) questionnaire.
Myasoedova E; De Thurah A; Erpelding ML; Schneeberger EE; Maribo T; Citera G; Davis JM; Matteson EL; Crowson CS; Fautrel B; Guillemin F
Semin Arthritis Rheum; 2020 Apr; 50(2):261-265. PubMed ID: 31526593
[TBL] [Abstract][Full Text] [Related]
13. Tapering towards DMARD-free remission in established rheumatoid arthritis: 2-year results of the TARA trial.
van Mulligen E; Weel AE; Hazes JM; van der Helm-van Mil A; de Jong PHP
Ann Rheum Dis; 2020 Sep; 79(9):1174-1181. PubMed ID: 32482645
[TBL] [Abstract][Full Text] [Related]
14. A multi-biomarker score measuring disease activity in rheumatoid arthritis patients tapering adalimumab or etanercept: predictive value for clinical and radiographic outcomes.
Bouman CAM; van der Maas A; van Herwaarden N; Sasso EH; van den Hoogen FHJ; den Broeder AA
Rheumatology (Oxford); 2017 Jun; 56(6):973-980. PubMed ID: 28339738
[TBL] [Abstract][Full Text] [Related]
15. Gradual tapering TNF inhibitors versus conventional synthetic DMARDs after achieving controlled disease in patients with rheumatoid arthritis: first-year results of the randomised controlled TARA study.
van Mulligen E; de Jong PHP; Kuijper TM; van der Ven M; Appels C; Bijkerk C; Harbers JB; de Man Y; Molenaar THE; Tchetverikov I; Goekoop-Ruiterman YPM; van Zeben J; Hazes JMW; Weel AEAM; Luime JJ
Ann Rheum Dis; 2019 Jun; 78(6):746-753. PubMed ID: 30954969
[TBL] [Abstract][Full Text] [Related]
16. Flares in rheumatoid arthritis: frequency and management. A report from the BRASS registry.
Bykerk VP; Shadick N; Frits M; Bingham CO; Jeffery I; Iannaccone C; Weinblatt M; Solomon DH
J Rheumatol; 2014 Feb; 41(2):227-34. PubMed ID: 24334643
[TBL] [Abstract][Full Text] [Related]
17. Flares in Rheumatoid Arthritis Patients with Low Disease Activity: Predictability and Association with Worse Clinical Outcomes.
Bechman K; Tweehuysen L; Garrood T; Scott DL; Cope AP; Galloway JB; Ma MHY
J Rheumatol; 2018 Nov; 45(11):1515-1521. PubMed ID: 30173149
[TBL] [Abstract][Full Text] [Related]
18. Impact of low disease activity, remission, and complete remission on flares following tapering of corticosteroids and immunosuppressive therapy in patients with systemic lupus erythematous: a multinational cohort study.
Cho J; Shen L; Huq M; Kandane-Rathnayake R; Golder V; Louthrenoo W; Chen YH; Hamijoyo L; Luo SF; Wu YJ; Zamora L; Li Z; Sockalingam S; Katsumata Y; Harigai M; Hao Y; Zhang Z; Basnayake D; Chan M; Kikuchi J; Takeuchi T; Bae SC; Oon S; O'Neill S; Goldblatt F; Ng KPL; Law A; Tugnet N; Kumar S; Tee C; Tee M; Ohkubo N; Tanaka Y; Navarra SV; Lau CS; Hoi A; Morand EF; Nikpour M; Lateef A;
Lancet Rheumatol; 2023 Oct; 5(10):e584-e593. PubMed ID: 38251484
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the RAID Score in Assessing Rheumatoid Arthritis Activity in Teleconsultation.
Avouac J; Molto A; Allanore Y
J Rheumatol; 2024 Jun; ():. PubMed ID: 38825352
[TBL] [Abstract][Full Text] [Related]
20. Patient- and clinician-reported outcomes for patients with new presentation of inflammatory arthritis: observations from the National Clinical Audit for Rheumatoid and Early Inflammatory Arthritis.
Ledingham JM; Snowden N; Rivett A; Galloway J; Ide Z; Firth J; MacPhie E; Kandala N; Dennison EM; Rowe I
Rheumatology (Oxford); 2017 Feb; 56(2):231-238. PubMed ID: 27694336
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
